Patient preferences for overall survival and chemotherapy side effects in lung and colon cancer

被引：0
|
作者：
Schmidt, K. [1 ]
Damm, K. [1 ]
von der Schulenburg, J. -M. [1 ]
机构：
[1] Leibniz Univ Hannover, CHERH, D-30167 Hannover, Germany
来源：
Oncology Research and Treatment | 2015年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P513
引用
收藏
页码：157 / 157
页数：1
相关论文
共 50 条
  • [1] Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer
    K. M. Islam
    T. Anggondowati
    P. E. Deviany
    J. E. Ryan
    A. Fetrick
    D. Bagenda
    M. S. Copur
    A. Tolentino
    I. Vaziri
    H. A. McKean
    S. Dunder
    J. E. Gray
    C. Huang
    A. K. Ganti
    [J]. BMC Cancer, 19
  • [2] Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer
    Islam, K. M.
    Anggondowati, T.
    Deviany, P. E.
    Ryan, J. E.
    Fetrick, A.
    Bagenda, D.
    Copur, M. S.
    Tolentino, A.
    Vaziri, I.
    McKean, H. A.
    Dunder, S.
    Gray, J. E.
    Huang, C.
    Ganti, A. K.
    [J]. BMC CANCER, 2019, 19 (01)
  • [3] Late-stage lung cancer patient preferences about chemotherapy treatment adverse side effects.
    Islam, K. M.
    Ryan, June
    Fetrick, Ann
    Ganti, Apar Kishor
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (03)
  • [4] Side effects of chemotherapy in lung cancer
    Rapti, A
    [J]. 3RD INTERNATIONAL CONGRESS ON LUNG CANCER, 1998, : 203 - 209
  • [5] Use of Conjoint Analysis to Assess Breast Cancer Patient Preferences for Chemotherapy Side Effects
    Beusterien, Kathleen
    Grinspan, Jessica
    Kuchuk, Iryna
    Mazzarello, Sasha
    Dent, Susan
    Gertler, Stan
    Bouganim, Nathaniel
    Vandermeer, Lisa
    Clemons, Mark
    [J]. ONCOLOGIST, 2014, 19 (02): : 127 - 134
  • [6] The effect of chemotherapy on overall survival of stage II colon cancer.
    Omaira, M.
    Mozayen, M.
    Katato, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [7] Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects
    Stefan Munker
    Michael Gerken
    Petra Fest
    Claudia Ott
    Elisabeth Schnoy
    Stefan Fichtner-Feigl
    Philipp Wiggermann
    Martin Vogelhuber
    Wolfgang Herr
    Christian Stroszczynski
    Hans Jürgen Schlitt
    Matthias Evert
    Michael Reng
    Monika Klinkhammer-Schalke
    Andreas Teufel
    [J]. BMC Cancer, 18
  • [8] Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects
    Munker, Stefan
    Gerken, Michael
    Fest, Petra
    Ott, Claudia
    Schnoy, Elisabeth
    Fichtner-Feigl, Stefan
    Wiggermann, Philipp
    Vogelhuber, Martin
    Herr, Wolfgang
    Stroszczynski, Christian
    Schlitt, Hans Juergen
    Evert, Matthias
    Reng, Michael
    Klinkhammer-Schalke, Monika
    Teufel, Andreas
    [J]. BMC CANCER, 2018, 18
  • [9] Patient preferences regarding side effects of chemotherapy for ovarian cancer: Do they change over time?
    Sun, CC
    Bodurka, DC
    Donato, ML
    Rubenstein, EB
    Borden, CL
    Basen-Engquist, K
    Munsell, MF
    Kavanagh, JJ
    Gershenson, DM
    [J]. GYNECOLOGIC ONCOLOGY, 2002, 87 (01) : 118 - 128
  • [10] Pembrolizumab-induced autoimmune side effects of colon and pancreas in a patient with lung cancer
    Kazuya Ofuji
    Katsushi Hiramatsu
    Takuto Nosaka
    Tatsushi Naito
    Kazuto Takahashi
    Hidetaka Matsuda
    Masahiro Ohtani
    Yoshiaki Imamura
    Tamotsu Ishizuka
    Yasunari Nakamoto
    [J]. Clinical Journal of Gastroenterology, 2021, 14 : 1692 - 1699
12345